Malander S - Search Results

1

[Ovarian cancer is in many ways a heterogeneous disease].

Malander S, Hjerpe E, Carlson J, Borg Å. Malander S, et al. Lakartidningen. 2015 Dec 8;112:DIUR. Lakartidningen. 2015. PMID: 26646956 Free article. Review. Swedish.

2

Two BRCA1-positive epithelial ovarian tumors with metastases to the central nervous system: a case report.

Koul A, Loman N, Malander S, Borg A, Ridderheim M. Koul A, et al. Among authors: malander s. Gynecol Oncol. 2001 Mar;80(3):399-402. doi: 10.1006/gyno.2000.6085. Gynecol Oncol. 2001. PMID: 11263939

3

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.

Malander S, Ridderheim M, Måsbäck A, Loman N, Kristoffersson U, Olsson H, Nilbert M, Borg A. Malander S, et al. Eur J Cancer. 2004 Feb;40(3):422-8. doi: 10.1016/j.ejca.2003.09.016. Eur J Cancer. 2004. PMID: 14746861

4

The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.

Malander S, Rambech E, Kristoffersson U, Halvarsson B, Ridderheim M, Borg A, Nilbert M. Malander S, et al. Gynecol Oncol. 2006 May;101(2):238-43. doi: 10.1016/j.ygyno.2005.10.029. Epub 2005 Dec 19. Gynecol Oncol. 2006. PMID: 16360201

5

Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40.

Domanska K, Malander S, Måsbäck A, Nilbert M. Domanska K, et al. Among authors: malander s. Int J Gynecol Cancer. 2007 Jul-Aug;17(4):789-93. doi: 10.1111/j.1525-1438.2007.00875.x. Epub 2007 Mar 5. Int J Gynecol Cancer. 2007. PMID: 17343610

6

Genetic profiles distinguish different types of hereditary ovarian cancer.

Domanska K, Malander S, Staaf J, Karlsson A, Borg A, Jönsson G, Nilbert M. Domanska K, et al. Among authors: malander s. Oncol Rep. 2010 Oct;24(4):885-95. doi: 10.3892/or.2010.885. Oncol Rep. 2010. PMID: 20811668

7

High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer.

Corvigno S, Mezheyeuski A, De La Fuente LM, Westbom-Fremer S, Carlson JW, Fernebro J, Åvall-Lundqvist E, Kannisto P, Hedenfalk I, Malander S, Rolny C, Dahlstrand H, Östman A. Corvigno S, et al. Among authors: malander s. Gynecol Oncol. 2020 Dec;159(3):860-868. doi: 10.1016/j.ygyno.2020.09.041. Epub 2020 Oct 5. Gynecol Oncol. 2020. PMID: 33032823

8

Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome.

Jönsson JM, Bartuma K, Dominguez-Valentin M, Harbst K, Ketabi Z, Malander S, Jönsson M, Carneiro A, Måsbäck A, Jönsson G, Nilbert M. Jönsson JM, et al. Among authors: malander s. Fam Cancer. 2014 Dec;13(4):537-45. doi: 10.1007/s10689-014-9728-1. Fam Cancer. 2014. PMID: 24848881 Free PMC article.

9

Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.

Jönsson JM, Johansson I, Dominguez-Valentin M, Kimbung S, Jönsson M, Bonde JH, Kannisto P, Måsbäck A, Malander S, Nilbert M, Hedenfalk I. Jönsson JM, et al. Among authors: malander s. PLoS One. 2014 Sep 16;9(9):e107643. doi: 10.1371/journal.pone.0107643. eCollection 2014. PLoS One. 2014. PMID: 25226589 Free PMC article.

10

Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.

Martín de la Fuente L, Malander S, Hartman L, Jönsson JM, Ebbesson A, Nilbert M, Måsbäck A, Hedenfalk I. Martín de la Fuente L, et al. Among authors: malander s. Int J Gynecol Pathol. 2018 Mar;37(2):101-109. doi: 10.1097/PGP.0000000000000394. Int J Gynecol Pathol. 2018. PMID: 28481779 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page